Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 02, 2018 11:27 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on Behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) stockholders concerning the...
September 28, 2016 11:25 ET | Source: Shareholders Foundation, Inc.

October 3rd Deadline in Lawsuit for Investors in shares of Keryx Biopharmaceuticals (NASDAQ:KERX) announced by Shareholders Foundation

SAN DIEGO, Sept. 28, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on October 3, 2016 in the lawsuit that was filed for certain investors in...
September 16, 2016 10:52 ET | Source: The Rosen Law Firm PA

KERYX ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action

NEW YORK, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Keryx Biopharmaceuticals, Inc. securities (NASDAQ:KERX) from February 25, 2016...
August 31, 2016 15:53 ET | Source: The Rosen Law Firm PA

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX

NEW YORK, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Keryx Biopharmaceuticals,...